These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14708623)

  • 1. Mice with genetically determined high susceptibility to ultraviolet (UV)-induced immunosuppression show enhanced UV carcinogenesis.
    Noonan FP; Muller HK; Fears TR; Kusewitt DF; Johnson TM; De Fabo EC
    J Invest Dermatol; 2003 Nov; 121(5):1175-81. PubMed ID: 14708623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of susceptibility to UV-induced immunosuppression by interacting quantitative trait loci.
    Clemens KE; Churchill G; Bhatt N; Richardson K; Noonan FP
    Genes Immun; 2000; 1(4):251-9. PubMed ID: 11196701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of photocarcinogenesis and UV-induced immunosuppression in mice by topical tannic acid.
    Gensler HL; Gerrish KE; Williams T; Rao G; Kittelson J
    Nutr Cancer; 1994; 22(2):121-30. PubMed ID: 14502841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in low-dose UV-induced suppression of contact hypersensitivity and in the skin photocarcinogenesis response.
    Yamawaki M; Katiyar SK; Anderson CY; Tubesing KA; Mukhtar H; Elmets CA
    J Invest Dermatol; 1997 Dec; 109(6):716-21. PubMed ID: 9406810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice.
    Noonan FP; Otsuka T; Bang S; Anver MR; Merlino G
    Cancer Res; 2000 Jul; 60(14):3738-43. PubMed ID: 10919643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet a irradiation of C57BL/6 mice suppresses systemic contact hypersensitivity or enhances secondary immunity depending on dose.
    Byrne SN; Spinks N; Halliday GM
    J Invest Dermatol; 2002 Oct; 119(4):858-64. PubMed ID: 12406331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide.
    Gensler HL
    Nutr Cancer; 1997; 29(2):157-62. PubMed ID: 9427980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental ultraviolet radiation carcinogenesis: I. Relationship of the major histocompatibility complex to tumor latency and immunogenecity.
    Roberts LK; Bernhard EJ; Daynes RA
    Photodermatol; 1984 Apr; 1(2):57-64. PubMed ID: 6531283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to immunosuppression by ultraviolet B radiation in the mouse.
    Noonan FP; Hoffman HA
    Immunogenetics; 1994; 39(1):29-39. PubMed ID: 8225436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of UVB immunosuppression in the mouse by autosomal and sex-linked genes.
    Noonan FP; Hoffman HA
    Immunogenetics; 1994; 40(4):247-56. PubMed ID: 8082890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity.
    Rebel H; Mosnier LO; Berg RJ; Westerman-de Vries A; van Steeg H; van Kranen HJ; de Gruijl FR
    Cancer Res; 2001 Feb; 61(3):977-83. PubMed ID: 11221893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of parent genetic background on latency and antigenicity of UV-induced tumors originating in F1 hybrids.
    Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
    Exp Dermatol; 1995 Feb; 4(1):42-5. PubMed ID: 7757331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet radiation-induced murine tumors produced in the absence of ultraviolet radiation-induced systemic tumor immunosuppression.
    Menzies SW; Greenoak GE; Reeve VE; Gallagher CH
    Cancer Res; 1991 Jun; 51(11):2772-9. PubMed ID: 2032217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary beta-carotene and ultraviolet-induced immunosuppression.
    Noonan FP; Webber LJ; De Fabo EC; Hoffman HA; Bendich A; Mathews-Roth M
    Clin Exp Immunol; 1996 Jan; 103(1):54-60. PubMed ID: 8565287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time and dose dependence of acceptance of UV-induced syngeneic tumor implants in chronically UV-exposed hairless mice.
    Sontag Y; Steerenberg P; Garssen J; van Loveren H; van der Leun JC; van Vloten WA; de Gruijl FR
    Photochem Photobiol; 1997 Feb; 65(2):342-6. PubMed ID: 9066309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An action spectrum for ultraviolet radiation-induced immunosuppression in humans.
    Damian DL; Matthews YJ; Phan TA; Halliday GM
    Br J Dermatol; 2011 Mar; 164(3):657-9. PubMed ID: 21375518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet-B dose-response curves for local and systemic immunosuppression are identical.
    Noonan FP; De Fabo EC
    Photochem Photobiol; 1990 Oct; 52(4):801-10. PubMed ID: 2089429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice.
    van Kranen HJ; Westerman A; Berg RJ; Kram N; van Kreijl CF; Wester PW; de Gruijl FR
    Mutat Res; 2005 Apr; 571(1-2):81-90. PubMed ID: 15748640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protects against skin cancer induction by UV-B radiation.
    Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
    Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. 1977.
    Fisher MS; Kripke ML
    Bull World Health Organ; 2002; 80(11):908-12. PubMed ID: 12481215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.